Toshimitsu Matsui
Overview
Explore the profile of Toshimitsu Matsui including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
116
Citations
972
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kashiwagi T, Kashiwagi Y, Suzuki T, Shingu M, Kashiwagi S, Hirata T, et al.
Rinsho Ketsueki
. 2024 Apr;
65(4):237-242.
PMID: 38684433
We report the case of a 48-year-old man who presented with fatigue and weight loss. A local physician observed elevated alkaline phosphatase levels, anemia, thrombocytopenia, and renal dysfunction. Fever also...
2.
Nakaya A, Shibayama H, Uoshima N, Yamamura R, Yoshioka S, Imada K, et al.
Leuk Res Rep
. 2023 Dec;
20:100395.
PMID: 38076634
To evaluate the specific prognostic value of CAs, we conducted an analysis of 923 symptomatic multiple myeloma patients. Among this cohort, 480 patients had complete data set of high-risk CAs...
3.
Shimura Y, Shibayama H, Nakaya A, Yamamura R, Imada K, Kaneko H, et al.
Int J Hematol
. 2023 Sep;
118(5):609-617.
PMID: 37668833
To investigate the real-world clinical outcomes and management of novel drug-containing therapies for newly diagnosed multiple myeloma (MM) patients, we retrospectively analyzed data on the first-line treatment for newly diagnosed...
4.
Minagawa K, Wakahashi K, Fukui C, Kawano Y, Kawano H, Suzuki T, et al.
Front Immunol
. 2023 Jun;
14:1197112.
PMID: 37304286
Loss of , found in several types of lymphoma, induces excessive CXCL13 secretion through RNA dysregulation contributing to body weight loss and early death in lymphoma model mice. Follicular lymphoma...
5.
Shimazu Y, Kanda J, Kaneko H, Imada K, Yamamura R, Kosugi S, et al.
Ther Adv Hematol
. 2022 Dec;
13:20406207221142487.
PMID: 36530751
Background: Daratumumab is one of the most widely used treatments for relapsed/refractory multiple myeloma (MM) patients. However, not all patients achieve a lasting therapeutic response with daratumumab. Objectives: We hypothesized...
6.
Tomita T, Kato M, Mishima T, Matsunaga Y, Sanjo H, Ito K, et al.
Nat Commun
. 2021 Jun;
12(1):3655.
PMID: 34135341
RNA in extracellular vesicles (EVs) are uptaken by cells, where they regulate fundamental cellular functions. EV-derived mRNA in recipient cells can be translated. However, it is still elusive whether "naked...
7.
Suzuki T, Ishii S, Shinohara M, Kawano Y, Wakahashi K, Kawano H, et al.
Haematologica
. 2021 Feb;
106(6):1671-1683.
PMID: 33538151
The mobilization efficiency of hematopoietic stem/progenitor cells from bone marrow (BM) to circulation by granulocyte colony-stimulating factor (G-CSF) is dramatically dispersed in humans and mice with no mechanistic lead for...
8.
Ishii S, Suzuki T, Wakahashi K, Asada N, Kawano Y, Kawano H, et al.
Blood
. 2021 Jan;
137(11):1457-1467.
PMID: 33512467
Fibroblast growth factor 23 (FGF-23) hormone is produced by bone-embedded osteocytes and regulates phosphate homeostasis in kidneys. We found that administration of granulocyte colony-stimulating factor (G-CSF) to mice induced a...
9.
Nakaya A, Tanaka H, Yagi H, Ohta K, Shibayama H, Kohara T, et al.
Int J Hematol
. 2020 Aug;
112(5):666-673.
PMID: 32783165
We retrospectively analyzed 51 patients with solitary plasmacytoma diagnosed from October 2002 to September 2018 from a cohort of 3575 patients with plasma cell dyscrasias registered in the Kansai Myeloma...
10.
Wakahashi K, Minagawa K, Kawano Y, Kawano H, Suzuki T, Ishii S, et al.
Blood
. 2019 Feb;
133(15):1619-1629.
PMID: 30718230
Myelofibrosis in myeloproliferative neoplasms (MPNs) with mutations such as JAK2V617F is an unfavorable sign for uncontrollable disease progression in the clinic and is complicated with osteosclerosis whose pathogenesis is largely...